Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3839-3843, July 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conner, M. K.
Right arrow Articles by Kawatani, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conner, M. K.
Right arrow Articles by Kawatani, N.

Sister Chromatid Exchange Induced by Etheno-ATP Derivatives in Vitro1

Mary K. Conner2, Ruth A. Modzelewski and Noriko Kawatani

Departments of Biostatistics and Industrial Environmental Health Sciences, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15162

Genotoxic activities of a series of commercially purchased 1,N6-ethenoadenosine ({varepsilon}-Ado) and {varepsilon}-deoxyadenosine ({varepsilon}-dAdo) derivatives were assessed using the sister chromatid exchange (SCE) assay in murine spleen lymphocytes in vitro. Of the {varepsilon}-Ado adducts evaluated for SCE induction {varepsilon}-ATP and {varepsilon}-dATP were highly active (5x baseline) SCE inducers over a concentration range of 50–150 µM. Moderate SCE-inducing activities were seen with {varepsilon}-dAdo, {varepsilon}-A, and {varepsilon}-AMP. {varepsilon}-A was of particular interest in that spleen lymphocytes from a single mouse were highly sensitive to SCE (>50 SCE/cell at 75 µM). {varepsilon}-Ado was weakly effective and {varepsilon}-ADP and {varepsilon}-dAMP did not produce significantly elevated SCEs. Cocanavalin A-stimulated T-lymphocytes and lipopolysaccharide-stimulated B-lymphocytes exhibited comparable SCE responses to {varepsilon}-A, {varepsilon}-AMP, and {varepsilon}-dATP. However, B-lymphocytes were considerably less sensitive than T-lymphocytes to {varepsilon}-dAdo and {varepsilon}-ATP.

Evaluation of the purities of specific {varepsilon}-Ado derivatives, as performed by high-performance liquid chromatography and thin layer chromatography, failed to detect potential contaminants as cytogenetically active agents. However, a difference (about threefold) in cytogenetic activities of two lot numbers of {varepsilon}-ATP paralleled the difference in UV absorbance of equivalent concentrations (mg/ml), prepared according to the manufacturers stated purity. Any impurities likely to be present were consistent with inactive nonchromophoric compounds such as buffer salts.

Because of the direct genotoxic activity of {varepsilon}-A in intact mammalian cells, we suggest that intracellular adenylate pools, including the prominent ubiquitous nucleotide ATP, are non-DNA targets for {varepsilon}-modification by active metabolites and the resulting {varepsilon}-adducts are likely to be active moieties in SCE induction and in neoplastic transformation produced by ethyl carbamate.

1 This research was supported in part by Research Grant R01-CA-39401-03 awarded to M. K. C. and by BRSG 2-SOT-RR05451-27 awarded by the Biomedical Research Support Grant Program, Division of Research Resources, NIH.

2 To whom requests for reprints should be addressed, at Genetic Toxicology, University of Pittsburgh, 732 Parran Hall, School of Public Health, Pittsburgh, PA 15261.

Received 12/12/88. Revised 3/31/89. Accepted 4/11/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.